Search
Medicaid Monitor
Saturday, November 21, 2026 · Updated Fri 12:06 PM MT · 52 stories on Friday, November 20
Medicaid Monitor Pro
Sat, Nov 21 · 52 stories on Friday, November 20PRO
← All stories
IndustryAugust 19, 2026

Trump Nominates White House Health Adviser Heidi Overton as FDA Commissioner

President Trump announced Wednesday he will nominate Dr. Heidi Overton, currently a White House domestic policy adviser on health issues, to serve as FDA Commissioner. The nomination comes amid significant staff turnover at the agency. If confirmed by the Senate, Overton would lead the FDA's oversight of prescription drugs, including Medicaid drug coverage policy and pharmaceutical manufacturer rebates. The nomination's impact on Medicaid will depend on Senate confirmation timing and Overton's policy priorities once in office.

Why it mattersFDA leadership influences Medicaid drug policy through approval decisions, labeling requirements, and manufacturer accountability that affect state formularies and rebate programs.

Pharmacy

Read the full article at thehill.com →
Share this briefing

You might also like

← All stories

Get the daily briefing.